Akshaya Bio Inc. – Product Pipeline Review

Global Markets Direct’s, ‘Akshaya Bio Inc. – Product Pipeline Review – 2016’, provides an overview of the Akshaya Bio Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Akshaya Bio Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.


The report provides a snapshot of the pipeline therapeutic landscape of Akshaya Bio Inc.

The report provides overview of Akshaya Bio Inc. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Akshaya Bio Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Akshaya Bio Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Akshaya Bio Inc.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Akshaya Bio Inc.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Akshaya Bio Inc.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Akshaya Bio Inc. Snapshot 5

Akshaya Bio Inc. Overview 5

Key Facts 5

Akshaya Bio Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Akshaya Bio Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Pipeline Products - Combination Treatment Modalities 10

Akshaya Bio Inc. - Pipeline Products Glance 11

Akshaya Bio Inc. - Early Stage Pipeline Products 11

Preclinical Products/Combination Treatment Modalities 11

Discovery Products/Combination Treatment Modalities 12

Akshaya Bio Inc. - Drug Profiles 13

hepatitis C vaccine - Drug Profile 13

Product Description 13

Mechanism Of Action 13

R&D Progress 13

HIV vaccine - Drug Profile 14

Product Description 14

Mechanism Of Action 14

R&D Progress 14

influenza [strains A/H5N1 + A/H1N1] vaccine - Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

malaria vaccine - Drug Profile 16

Product Description 16

Mechanism Of Action 16

R&D Progress 16

NU-500 - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

Vaccine to Target CA9 for Cancer - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

Vaccine to Target CEA for Oncology - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

Vaccine to Target HER 2/neu for Cancer - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

Vaccine to Target MUC1 for Oncology - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

Vaccine to Target PAP for Prostate Cancer - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

Westrern Equine Encephalitis Virus Vaccine - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

Akshaya Bio Inc. - Pipeline Analysis 24

Akshaya Bio Inc. - Pipeline Products by Target 24

Akshaya Bio Inc. - Pipeline Products by Molecule Type 26

Akshaya Bio Inc. - Locations And Subsidiaries 27

Head Office 27

Appendix 28

Methodology 28

Coverage 28

Secondary Research 28

Primary Research 28

Expert Panel Validation 28

Contact Us 28

Disclaimer 29

List of Tables

List of Tables

Akshaya Bio Inc., Key Facts 5

Akshaya Bio Inc. – Pipeline by Indication, 2016 7

Akshaya Bio Inc. – Pipeline by Stage of Development, 2016 8

Akshaya Bio Inc. – Monotherapy Products in Pipeline, 2016 9

Akshaya Bio Inc. – Combination Treatment Modalities in Pipeline, 2016 10

Akshaya Bio Inc. – Preclinical, 2016 11

Akshaya Bio Inc. – Discovery, 2016 12

Akshaya Bio Inc. – Pipeline by Target, 2016 25

Akshaya Bio Inc. – Pipeline by Molecule Type, 2016 26

List of Figures

List of Figures

Akshaya Bio Inc. – Pipeline by Top 10 Indication, 2016 7

Akshaya Bio Inc. – Pipeline by Stage of Development, 2016 8

Akshaya Bio Inc. – Monotherapy Products in Pipeline, 2016 9

Akshaya Bio Inc. – Pipeline by Top 10 Target, 2016 24

Akshaya Bio Inc. – Pipeline by Molecule Type, 2016 26


Discounts available for multiple report purchases.

+44 (0) 161 359 5414

Saved reports